Search the Newsroom
Filter By
Showing 291 - 300 of 3019 results
CHOP and Vanderbilt Researchers to Lead $7.37 Million Kidney Stone Research Project
Researchers from Children’s Hospital of Philadelphia (CHOP) and Vanderbilt University Medical Center were awarded a $7.37 million RC2 grant from the National Institutes of Health (NIH) to lead a five-year multisite project across the U.S. focused on kidney stone disease research.
Children’s Hospital of Philadelphia Study Highlights Deeper Understanding of Genetic Links between Childhood Speech and Language Disorders
Researchers at Children’s Hospital of Philadelphia (CHOP) announced the results of a new study highlighting significant genetic links in speech and language disorders in children.
Feature Article: What’s in Vaccines and Why?
Find resources related to vaccine ingredients. Plus, get tools to help evaluate information about this and other science-based topics.
Dr. Handy’s Corner: Why Are Certain Vaccines Mandated for School?
Watch as Dr. Handy discusses the history of vaccine mandates and the role they play in keeping children healthy today.
Vaccine News & Notes — October 2024
Find info about influenza deaths in children during the 2023-24 season and check out new RSV Q&A sheets.
Researchers at Children’s Hospital of Philadelphia Highlight Role of Alternative Splicing in Chemotherapy Resistance
Researchers at Children’s Hospital of Philadelphia (CHOP) have elucidated the significant role that alternative splicing – a process whereby a single gene produces multiple proteins by rearranging its messenger RNA segments in different combinations – plays in resistance to chemotherapy in relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL). The study published today in the journal Cancer Research.
Penn Medicine and Children’s Hospital of Philadelphia Create mRNA Vaccine to Prevent and Treat C. difficile
The vaccine is the first mRNA vaccine against C. difficile and would be the first vaccine in general to successfully ward off the bacterial infection.
$14M NIH grant funds gene-editing research for rare metabolic diseases at Penn and CHOP
Researchers aim to develop personalized therapies for urea cycle disorders and other genetic conditions using advanced CRISPR technology.
CHOP Cell and Gene Therapy Researcher Receives NIH New Innovator Award
Evan Weber will use this “high risk, high reward” grant to fund research into improving CAR-T therapies.
Researchers at Children’s Hospital of Philadelphia Highlight Benefits of Proton Therapy for Pediatric Hodgkin Lymphoma Patients
A new study from Children’s Hospital of Philadelphia (CHOP) showed promising results for Pediatric Hodgkin Lymphoma (pHL) patients who underwent proton therapy to treat their disease in rare regions located below the diaphragm, such as the abdomen and pelvis. The study highlights the advantages of proton therapy over conventional photon radiotherapy, demonstrating fewer side effects and better protection for critical organs. It was published recently in the journal Pediatric Blood and Cancer.